Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 14 04:00PM ET
49.72
Dollar change
+6.23
Percentage change
14.33
%
Index- P/E- EPS (ttm)-4.36 Insider Own4.30% Shs Outstand85.74M Perf Week25.21%
Market Cap4.26B Forward P/E- EPS next Y-3.87 Insider Trans-1.35% Shs Float82.09M Perf Month27.36%
Income-366.25M PEG- EPS next Q-1.22 Inst Own69.46% Short Float23.74% Perf Quarter-1.99%
Sales37.31M P/S114.30 EPS this Y-8.74% Inst Trans-0.98% Short Ratio10.03 Perf Half Y7.13%
Book/sh22.53 P/B2.21 EPS next Y18.09% ROA-16.38% Short Interest19.49M Perf Year-31.68%
Cash/sh22.20 P/C2.24 EPS next 5Y32.09% ROE-19.20% 52W Range36.52 - 91.10 Perf YTD26.32%
Dividend Est.- P/FCF- EPS past 5Y- ROI-17.13% 52W High-45.42% Beta1.78
Dividend TTM- Quick Ratio22.07 Sales past 5Y31550.17% Gross Margin-247.24% 52W Low36.14% ATR (14)2.65
Dividend Ex-Date- Current Ratio22.07 EPS Y/Y TTM-123.71% Oper. Margin-1250.38% RSI (14)70.23 Volatility6.79% 5.25%
Employees393 Debt/Eq0.12 Sales Y/Y TTM-89.95% Profit Margin-981.54% Recom1.90 Target Price80.33
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q-139.74% Payout- Rel Volume3.97 Prev Close43.49
Sales Surprise343.09% EPS Surprise63.35% Sales Q/Q-82.26% EarningsFeb 11 AMC Avg Volume1.94M Price49.72
SMA2018.25% SMA5016.36% SMA2000.40% Trades Volume7,722,737 Change14.33%
Date Action Analyst Rating Change Price Target Change
Feb-14-25Upgrade Evercore ISI In-line → Outperform $60 → $99
Feb-12-25Upgrade TD Cowen Sell → Hold $35
Feb-03-25Initiated H.C. Wainwright Buy $65
Aug-06-24Reiterated Needham Buy $88 → $84
Aug-02-24Initiated Rodman & Renshaw Buy $90
Jun-28-24Resumed Guggenheim Neutral
Feb-15-24Initiated Wolfe Research Peer Perform
Dec-11-23Downgrade TD Cowen Market Perform → Underperform $30
Oct-17-23Downgrade Cantor Fitzgerald Overweight → Neutral
Sep-27-23Initiated Mizuho Buy $82
Feb-16-25 05:34AM
Feb-15-25 02:00AM
Feb-14-25 12:20PM
10:38AM
Feb-12-25 06:37PM
11:26AM Loading…
11:26AM
10:25AM
Feb-11-25 05:10PM
04:01PM
Feb-10-25 05:50PM
06:15AM
Feb-06-25 08:13PM
Feb-04-25 06:00PM
Jan-30-25 01:50PM
Jan-29-25 05:50PM
08:00AM Loading…
08:00AM
Jan-24-25 06:00PM
Jan-23-25 08:30AM
04:15AM
Jan-17-25 11:16AM
Jan-16-25 08:00AM
03:15AM
Jan-14-25 06:00PM
04:34AM
Jan-13-25 07:00AM
Jan-09-25 04:20AM
Jan-08-25 08:30AM
Jan-07-25 06:00PM
08:00AM
07:19AM
05:50PM Loading…
Dec-31-24 05:50PM
Dec-30-24 03:47PM
Dec-29-24 06:36AM
Dec-26-24 06:00PM
Dec-22-24 12:25PM
Dec-20-24 09:30AM
Dec-17-24 05:29AM
Dec-14-24 09:45AM
Dec-12-24 12:37PM
Dec-11-24 11:45AM
Dec-09-24 12:00PM
Dec-07-24 08:45AM
Dec-06-24 12:00PM
Dec-05-24 11:30AM
05:27AM
Dec-02-24 05:44PM
Nov-30-24 04:35AM
Nov-24-24 05:47AM
Nov-23-24 06:30AM
Nov-21-24 05:15PM
Nov-19-24 07:03PM
Nov-18-24 06:53AM
Nov-17-24 05:11PM
Nov-16-24 06:00AM
Nov-15-24 05:45AM
Nov-14-24 08:30AM
Nov-13-24 06:30AM
Nov-08-24 05:20PM
01:22PM
Nov-07-24 08:00AM
Nov-06-24 12:42PM
09:55AM
Nov-05-24 10:10AM
09:01AM
05:00AM
Nov-04-24 09:35AM
09:30AM
Nov-02-24 10:00AM
Oct-31-24 04:02AM
Oct-26-24 06:32AM
Oct-25-24 05:50PM
Oct-22-24 11:50AM
Oct-21-24 06:00PM
09:55AM
Oct-19-24 07:30AM
Oct-16-24 03:47PM
09:45AM
Oct-15-24 06:00PM
Oct-13-24 06:30AM
Oct-12-24 08:30AM
Oct-08-24 06:00PM
Oct-05-24 04:25AM
Oct-04-24 07:13PM
Oct-02-24 06:00PM
05:00AM
04:55AM
Sep-25-24 06:00PM
Sep-21-24 07:36AM
Sep-19-24 05:50PM
04:33AM
Sep-18-24 06:00PM
Sep-12-24 08:45AM
04:15AM
Sep-10-24 05:50PM
Sep-08-24 04:51PM
11:49AM
Sep-05-24 08:45AM
Sep-04-24 11:30AM
Sep-02-24 06:15PM
Aug-30-24 08:19PM
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kulkarni SamarthChief Executive OfficerDec 24 '24Option Exercise16.2113,751222,904195,291Dec 27 05:35 PM
Kulkarni SamarthChief Executive OfficerDec 02 '24Sale55.1015,000826,564181,540Dec 04 05:35 PM
Kulkarni SamarthChief Executive OfficerNov 11 '24Sale55.6230,0001,668,678196,540Nov 13 05:35 PM
KASINGER JAMES R.General Counsel and SecretaryOct 14 '24Sale46.281,08950,39962,597Oct 15 06:00 PM
Kulkarni SamarthChief Executive OfficerOct 14 '24Sale46.284,293198,680226,540Oct 15 06:00 PM
Bruno JulianneChief Operating OfficerJun 21 '24Sale56.093,366188,7996,745Jun 24 05:35 PM
Kulkarni SamarthChief Executive OfficerApr 15 '24Option Exercise19.1219,582374,408227,704Apr 17 05:45 PM
Kulkarni SamarthChief Executive OfficerApr 15 '24Sale59.9119,5821,173,232208,122Apr 17 05:45 PM
Prasad RajuChief Financial OfficerMar 15 '24Sale72.693,524256,1606,476Mar 18 05:45 PM
Kulkarni SamarthChief Executive OfficerMar 15 '24Option Exercise19.1220,000382,400228,122Mar 18 05:45 PM
Kulkarni SamarthChief Executive OfficerMar 15 '24Sale72.4820,0001,449,628208,122Mar 18 05:45 PM
KASINGER JAMES R.General Counsel and SecretaryMar 11 '24Sale78.262,801219,20660,070Mar 12 05:45 PM
KASINGER JAMES R.General Counsel and SecretaryMar 12 '24Sale74.441,14685,30861,174Mar 12 05:45 PM
Kulkarni SamarthChief Executive OfficerMar 11 '24Sale78.269,802767,105203,705Mar 12 05:45 PM
Kulkarni SamarthChief Executive OfficerMar 12 '24Sale74.444,583341,159208,122Mar 12 05:45 PM
KASINGER JAMES R.General Counsel and SecretaryFeb 20 '24Sale79.671,913152,40957,371Feb 21 05:45 PM
Kulkarni SamarthChief Executive OfficerFeb 20 '24Sale79.676,370507,498194,257Feb 21 05:45 PM